LIPOCINE INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.798 USD | +5.44% |
|
-8.96% | +71.96% |
| Apr. 12 | Lipocine Says LPCN 2401 Shows Improved Body Composition in Mid-Stage Trial | MT |
| Apr. 11 | Top Premarket Gainers | MT |
Chart calendar Lipocine Inc.
c520ee2effee4eb27bb640b.tq9XNx995RXdodmTYN9vrxLgfK5jyAWZPLcTA22xI-Y.8eBjRkwJp12n5L7xJI4m5muTDsgwmnLQX9t3dAP6a7zM7BZ8TjqMf4qQjA~01b2fe56ab700446eadfecc94fc52bf8
Upcoming events on Lipocine Inc.
Past events on Lipocine Inc.
| 2024-04-11 08:30 am | LPCN 2401 Phase 2 Clinical Study Results Call |
| 2024-03-18 01:00 pm | Roth Conference |
| 2024-03-07 08:00 am | Q4 2023 Earnings Release |
| 2024-01-08 | LifeSci Partners Corporate Access Event |
| 2024-01-08 06:00 pm | Biotech Showcase |
| 2023-11-13 02:45 pm | American Association for the Study of Liver Diseases Conference - Abstract Number 5003 |
| 2023-11-08 08:00 am | Q3 2023 Earnings Release |
| 2023-10-24 03:00 pm | H.C. Wainwright NASH Investor Conference |
| 2023-09-27 03:00 pm | Cantor Fitzgerald Global Healthcare Conference |
| 2023-08-10 08:00 am | Q2 2023 Earnings Release |
| 2023-07-27 08:30 am | LPCN 1148 Phase 2 Clinical Study Results Call |
| 2023-06-26 07:00 am | H.C. Wainwright Neuropsychiatry Virtual Conference |
| 2023-06-24 09:30 am | European Association for the Study of the Liver Congress |
| 2023-06-23 03:00 am | European Association for the Study of the Liver Congress - Poster No: FRI-466 |
| 2023-06-21 03:00 am | European Association for the Study of the Liver Congress - Poster No: WED-358 |
| 2023-05-16 08:30 am | LPCN 1154 Phase I LiFT Study Results Call |
| 2023-05-11 06:00 am | Q1 2023 Earnings Release |
| 2023-05-10 12:00 pm | Annual General Meeting |
| 2023-03-10 08:30 am | Q4 2022 Earnings Release |
| 2023-01-11 12:00 pm | Biotech Showcase |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,16 0,20 -17.51% | 0,00 0,00 - | 16,1 3,75 330.23% | 0,50 1,41 -64.51% | -2,85 -3,07 7.05% | 2,03 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -12,9 -12,5 -3.2% | -18,0 -17,1 -5.07% | 3,15 -10,5 130.09% | -12,1 -12,4 2.5% | -17,9 -19,3 7.14% | -13,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -13,0 -12,8 -1.62% | -21,0 -20,4 -2.55% | -0,63 -13,0 95.11% | -10,8 -11,3 5.14% | -16,4 -18,0 9.11% | -13,2 |
|
Net income Million USD | Released Forecast Spread | -13,0 -12,8 -1.62% | -21,0 -20,4 -2.55% | -0,63 -13,0 95.11% | -10,8 -11,3 5.13% | -16,4 -18,0 9.11% | -12,5 |
|
EPS USD | Released Forecast Spread | -8,50 -8,50 0% | -6,46 -6,29 -2.7% | -0,17 -2,49 93.18% | -2,04 -2,21 7.69% | -3,10 -2,99 -3.68% | -1,49 |
| Announcement Date | 13/03/20 | 11/03/21 | 09/03/22 | 10/03/23 | 07/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 16,1 3,67 338.7% | 0,00 2,00 - | 0,50 0,26 94.55% | 0,00 0,70 - | 0,00 0,91 - | 0,05 0,78 -92.92% | 0,00 0,26 - | -3,12 0,31 -1116.94% | 0,22 0,00 - | 0,00 | 0,41 | 0,55 | 1,07 |
|
EBIT Million USD | Released Forecast Spread | 12,8 -0,84 1618.88% | -3,13 -1,52 -105.69% | -3,53 -3,37 -4.8% | -2,90 -3,07 5.5% | -2,56 -2,90 11.73% | -4,34 -2,47 -75.62% | -3,96 -3,31 -19.48% | -7,04 -3,20 -120.24% | -2,59 -3,97 34.69% | -3,73 | -3,41 | -3,35 | -2,92 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 12,6 -0,89 1515.77% | -3,49 -1,50 -132.89% | -2,63 -3,38 22.2% | -2,41 -3,05 21.05% | -2,23 -2,83 21.11% | -3,87 -2,45 -58.25% | -3,55 -3,33 -6.65% | -6,65 -3,22 -106.36% | -2,28 -3,92 41.81% | -3,68 | -3,36 | -3,30 | -2,87 |
|
Net income Million USD | Released Forecast Spread | 12,6 -0,89 1515.77% | -3,49 -1,50 -132.91% | -2,63 -3,38 22.2% | -2,41 -3,05 21.05% | -2,23 -2,83 21.09% | -3,87 -2,45 -58.26% | -3,55 -3,33 -6.65% | -6,65 -3,22 -106.36% | -2,28 -3,92 41.79% | -3,68 | -3,36 | -3,30 | -2,87 |
|
EPS USD | Released Forecast Spread | 2,38 -0,17 1500% | -0,68 -0,34 -100% | -0,51 -0,68 25% | -0,51 -0,57 10% | -0,34 -0,51 33.33% | -0,68 -0,43 -60% | -0,68 -0,64 -6.25% | -1,26 -0,60 -110% | -0,42 -0,47 10.64% | -0,68 | -0,62 | -0,29 | -0,25 |
| Announcement Date | 09/03/22 | 09/05/22 | 08/08/22 | 09/11/22 | 10/03/23 | 11/05/23 | 10/08/23 | 08/11/23 | 07/03/24 | - | - | - | - |
More events
Past sector events for Lipocine Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- LPCN Stock
- Calendar Lipocine Inc.
